N-(4-((4-Chlorobenzyl)oxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide

Catalog No. :
ACDOLJ827
CAS No. :
1415834-63-7
Molecular Formula :
C20H15ClF2N2O2
Molecular Weight :
388.80

IUPAC Name:N-(4-((4-chlorobenzyl)oxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide

N-(4-((4-Chlorobenzyl)oxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
5mg99%$58.00Login to see priceIn stockInquiry
10mg99%$95.00Login to see priceIn stockInquiry
25mg99%$189.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameN-(4-((4-Chlorobenzyl)oxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide
IUPAC NameN-(4-((4-chlorobenzyl)oxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide
MDL No.MFCD29472572
Molecular FormulaC20H15ClF2N2O2
Molecular Weight388.80
SMILESO=C(NC1=NC=CC(OCC2=CC=C(Cl)C=C2)=C1)CC3=C(F)C=CC=C3F
InChI KeyGISJHCLTIVIGLX-UHFFFAOYSA-N
SynonymN-(4-((4-Chlorobenzyl)oxy)pyridin-2-yl)-2-(2,6-difluorophenyl)acetamide
CAS No.1415834-63-7
PubChem CID71089297

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H315-H319-H335
Precautionary Statement(s)
P261-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACDOLJ827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACKPFN013 route compound structure diagram
    ACKPFN01385068-28-6 In Stock
  4. Then
  5. ACDOLJ827 route product structure diagram
    ACDOLJ8271415834-63-7 In Stock
Inquiry

2. ACDOLJ827 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACFUNX261 route compound structure diagram
    ACFUNX261116622-90-3 In Stock
  4. Then
  5. ACDOLJ827 route product structure diagram
    ACDOLJ8271415834-63-7 In Stock
Inquiry

Comments (0)